Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway S Basu, RJ Binder, R Suto, KM Anderson, PK Srivastava International immunology 12 (11), 1539-1546, 2000 | 1739 | 2000 |
CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin S Basu, RJ Binder, T Ramalingam, PK Srivastava Immunity 14 (3), 303-313, 2001 | 1478 | 2001 |
Heat shock protein–peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity NE Blachere, Z Li, RY Chandawarkar, R Suto, NS Jaikaria, S Basu, ... The Journal of experimental medicine 186 (8), 1315-1322, 1997 | 805 | 1997 |
Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world PK Srivastava, A Menoret, S Basu, RJ Binder, KL McQuade Immunity 8 (6), 657-665, 1998 | 773 | 1998 |
Efficacy, safety, and biomarkers of response to azacitidine and nivolumab in relapsed/refractory acute myeloid leukemia: a nonrandomized, open-label, phase II study N Daver, G Garcia-Manero, S Basu, PC Boddu, M Alfayez, JE Cortes, ... Cancer discovery 9 (3), 370-383, 2019 | 449 | 2019 |
Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells S Somersan, M Larsson, JF Fonteneau, S Basu, P Srivastava, N Bhardwaj The journal of immunology 167 (9), 4844-4852, 2001 | 388 | 2001 |
Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor-and peptide-specific immunity S Basu, PK Srivastava The Journal of experimental medicine 189 (5), 797-802, 1999 | 355 | 1999 |
Ipilimumab with stereotactic ablative radiation therapy: phase I results and immunologic correlates from peripheral T cells C Tang, JW Welsh, P De Groot, E Massarelli, JY Chang, KR Hess, S Basu, ... Clinical Cancer Research 23 (6), 1388-1396, 2017 | 298 | 2017 |
Cutting edge: heat shock protein gp96 induces maturation and migration of CD11c+ cells in vivo RJ Binder, KM Anderson, S Basu, PK Srivastava The Journal of Immunology 165 (11), 6029-6035, 2000 | 292 | 2000 |
Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer J Blando, A Sharma, MG Higa, H Zhao, L Vence, SS Yadav, J Kim, ... Proceedings of the National Academy of Sciences 116 (5), 1692-1697, 2019 | 289 | 2019 |
Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma S Goswami, T Walle, AE Cornish, S Basu, S Anandhan, I Fernandez, ... Nature medicine 26 (1), 39-46, 2020 | 271 | 2020 |
The distribution of T‐cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia P Williams, S Basu, G Garcia‐Manero, CS Hourigan, KA Oetjen, ... Cancer 125 (9), 1470-1481, 2019 | 257 | 2019 |
Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma J Gao, N Navai, O Alhalabi, A Siefker-Radtke, MT Campbell, RS Tidwell, ... Nature medicine 26 (12), 1845-1851, 2020 | 217 | 2020 |
Heat shock proteins: the fountainhead of innate and adaptive immune responses S Basu, PK Srivastava Cell stress & chaperones 5 (5), 443, 2000 | 193 | 2000 |
Immunological role of neuronal receptor vanilloid receptor 1 expressed on dendritic cells S Basu, P Srivastava Proceedings of the National Academy of Sciences 102 (14), 5120-5125, 2005 | 177 | 2005 |
Endocannabinoid system acts as a regulator of immune homeostasis in the gut N Acharya, S Penukonda, T Shcheglova, AT Hagymasi, S Basu, ... Proceedings of the National Academy of Sciences 114 (19), 5005-5010, 2017 | 151 | 2017 |
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial AO Kaseb, E Hasanov, HST Cao, L Xiao, JN Vauthey, SS Lee, BG Yavuz, ... The Lancet Gastroenterology & Hepatology 7 (3), 208-218, 2022 | 134 | 2022 |
Fever‐like temperature induces maturation of dendritic cells through induction of hsp90 S Basu, PK Srivastava International immunology 15 (9), 1053-1061, 2003 | 122 | 2003 |
Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 study F Ravandi, R Assi, N Daver, CB Benton, T Kadia, PA Thompson, ... The Lancet Haematology 6 (9), e480-e488, 2019 | 120 | 2019 |
ARID1A mutation plus CXCL13 expression act as combinatorial biomarkers to predict responses to immune checkpoint therapy in mUCC S Goswami, Y Chen, S Anandhan, PM Szabo, S Basu, JM Blando, W Liu, ... Science translational medicine 12 (548), eabc4220, 2020 | 90 | 2020 |